LTB4 Sweden
2004
FOUNDED
OOB
STATUS
1-10
EMPLOYEES
Liquidation
LATEST DEAL TYPE
Description
Developer of small molecule intended to target diseases such as infections and cancer. The company's small molecule is made by using arachidonic acid metabolite leukotriene B4 (LTB4) to innate immunity system for targeting diseases, enabling patients to avail enhanced care without any side effects.
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Primary Office
- Kornhamstorg 53
- 111 27 Stockholm
- Sweden
+46 08-442 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore LTB4 Sweden’s full profile, request a free trial.
LTB4 Sweden Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Bankruptcy: Liquidation | Completed | Bankruptcy: Liquidation | ||||
| 1. Early Stage VC | Completed | Generating Revenue |